Pathway Name Avg Num Perturbations Total Perturbations Num Entities Min Mean Truth Max Mean Truth Min Mean Within Max Mean Within Min Mean Any Max Mean Within TCGA08_retinoblastoma 58.0 465.0 8.0 -0.141 0.074 1000.0 -1000.0 -0.024 -1000.0 IL4-mediated signaling events 47.0 4284.0 91.0 -0.803 0.681 1000.0 -1000.0 -0.183 -1000.0 FOXA2 and FOXA3 transcription factor networks 46.0 2143.0 46.0 -0.612 0.011 1000.0 -1000.0 -0.099 -1000.0 Nephrin/Neph1 signaling in the kidney podocyte 43.0 1489.0 34.0 -0.154 0.011 1000.0 -1000.0 -0.059 -1000.0 Signaling events regulated by Ret tyrosine kinase 40.0 3301.0 82.0 -0.221 0.011 1000.0 -1000.0 -0.091 -1000.0 IL23-mediated signaling events 33.0 2035.0 60.0 -0.471 0.011 1000.0 -1000.0 -0.201 -1000.0 Wnt signaling 32.0 226.0 7.0 -0.145 -0.025 1000.0 -1000.0 -0.039 -1000.0 Syndecan-1-mediated signaling events 30.0 1043.0 34.0 -0.212 0.011 1000.0 -1000.0 -0.066 -1000.0 TCGA08_p53 29.0 205.0 7.0 -0.114 0.066 1000.0 -1000.0 -0.024 -1000.0 Syndecan-4-mediated signaling events 29.0 2009.0 67.0 -0.207 0.016 1000.0 -1000.0 -0.093 -1000.0 TCR signaling in naïve CD8+ T cells 27.0 2590.0 93.0 -0.16 0.02 1000.0 -1000.0 -0.092 -1000.0 amb2 Integrin signaling 26.0 2150.0 82.0 -0.254 0.014 1000.0 -1000.0 -0.088 -1000.0 Visual signal transduction: Cones 25.0 959.0 38.0 -0.17 0.011 1000.0 -1000.0 -0.065 -1000.0 Signaling events mediated by the Hedgehog family 24.0 1293.0 52.0 -0.235 0.129 1000.0 -1000.0 -0.081 -1000.0 Noncanonical Wnt signaling pathway 24.0 629.0 26.0 -0.145 0.011 1000.0 -1000.0 -0.066 -1000.0 Glypican 2 network 24.0 99.0 4.0 -0.028 -0.028 1000.0 -1000.0 -0.023 -1000.0 Class IB PI3K non-lipid kinase events 23.0 69.0 3.0 -0.034 -1000.0 1000.0 -1000.0 -0.02 -1000.0 IL12-mediated signaling events 22.0 1957.0 87.0 -0.236 0.035 1000.0 -1000.0 -0.142 -1000.0 Calcineurin-regulated NFAT-dependent transcription in lymphocytes 22.0 1557.0 68.0 -0.281 0.119 1000.0 -1000.0 -0.152 -1000.0 BMP receptor signaling 21.0 1716.0 81.0 -0.255 0.037 1000.0 -1000.0 -0.097 -1000.0 Endothelins 21.0 2069.0 96.0 -0.201 0.012 1000.0 -1000.0 -0.098 -1000.0 Ephrin B reverse signaling 20.0 1005.0 48.0 -0.145 0.015 1000.0 -1000.0 -0.081 -1000.0 Effects of Botulinum toxin 20.0 528.0 26.0 -0.16 0.014 1000.0 -1000.0 -0.067 -1000.0 Visual signal transduction: Rods 20.0 1073.0 52.0 -0.146 0.011 1000.0 -1000.0 -0.084 -1000.0 Thromboxane A2 receptor signaling 19.0 2004.0 105.0 -0.12 0.035 1000.0 -1000.0 -0.073 -1000.0 p75(NTR)-mediated signaling 19.0 2379.0 125.0 -0.187 0.033 1000.0 -1000.0 -0.125 -1000.0 Glypican 1 network 19.0 956.0 48.0 -0.191 0.021 1000.0 -1000.0 -0.059 -1000.0 Caspase cascade in apoptosis 18.0 1403.0 74.0 -0.167 0.062 1000.0 -1000.0 -0.047 -1000.0 Fc-epsilon receptor I signaling in mast cells 18.0 1785.0 97.0 -0.157 0.029 1000.0 -1000.0 -0.084 -1000.0 RXR and RAR heterodimerization with other nuclear receptor 18.0 957.0 52.0 -0.212 0.032 1000.0 -1000.0 -0.057 -1000.0 Glucocorticoid receptor regulatory network 17.0 1975.0 114.0 -0.415 0.236 1000.0 -1000.0 -0.089 -1000.0 Reelin signaling pathway 17.0 955.0 56.0 -0.196 0.027 1000.0 -1000.0 -0.091 -1000.0 Calcium signaling in the CD4+ TCR pathway 17.0 527.0 31.0 -0.159 0.011 1000.0 -1000.0 -0.09 -1000.0 BCR signaling pathway 17.0 1703.0 99.0 -0.186 0.017 1000.0 -1000.0 -0.095 -1000.0 ErbB4 signaling events 16.0 1128.0 69.0 -0.219 0.146 1000.0 -1000.0 -0.092 -1000.0 Ephrin A reverse signaling 16.0 116.0 7.0 -0.027 -0.0 1000.0 -1000.0 -0.027 -1000.0 HIF-1-alpha transcription factor network 16.0 1251.0 76.0 -0.249 0.045 1000.0 -1000.0 -0.217 -1000.0 LPA4-mediated signaling events 15.0 190.0 12.0 -0.147 0.016 1000.0 -1000.0 -0.029 -1000.0 Retinoic acid receptors-mediated signaling 14.0 831.0 58.0 -0.203 0.023 1000.0 -1000.0 -0.087 -1000.0 Nongenotropic Androgen signaling 14.0 734.0 52.0 -0.085 0.013 1000.0 -1000.0 -0.067 -1000.0 IL27-mediated signaling events 14.0 721.0 51.0 -0.115 0.057 1000.0 -1000.0 -0.098 -1000.0 Signaling events mediated by PTP1B 13.0 993.0 76.0 -0.1 0.028 1000.0 -1000.0 -0.076 -1000.0 LPA receptor mediated events 13.0 1378.0 102.0 -0.115 0.021 1000.0 -1000.0 -0.104 -1000.0 Neurotrophic factor-mediated Trk receptor signaling 13.0 1619.0 120.0 -0.222 0.05 1000.0 -1000.0 -0.078 -1000.0 Coregulation of Androgen receptor activity 12.0 937.0 76.0 -0.175 0.019 1000.0 -1000.0 -0.064 -1000.0 Signaling events mediated by HDAC Class III 12.0 491.0 40.0 -0.182 0.101 1000.0 -1000.0 -0.047 -1000.0 Syndecan-3-mediated signaling events 12.0 445.0 35.0 -0.165 0.033 1000.0 -1000.0 -0.068 -1000.0 Signaling events mediated by Stem cell factor receptor (c-Kit) 12.0 974.0 78.0 -0.075 0.036 1000.0 -1000.0 -0.085 -1000.0 ErbB2/ErbB3 signaling events 11.0 741.0 65.0 -0.144 0.016 1000.0 -1000.0 -0.075 -1000.0 Osteopontin-mediated events 11.0 454.0 38.0 -0.097 0.012 1000.0 -1000.0 -0.12 -1000.0 Syndecan-2-mediated signaling events 11.0 802.0 69.0 -0.091 0.024 1000.0 -1000.0 -0.066 -1000.0 EPHB forward signaling 11.0 958.0 85.0 -0.077 0.069 1000.0 -1000.0 -0.106 -1000.0 Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 11.0 364.0 33.0 -0.15 0.032 1000.0 -1000.0 -0.075 -1000.0 Regulation of nuclear SMAD2/3 signaling 10.0 1418.0 136.0 -0.251 0.151 1000.0 -1000.0 -0.08 -1000.0 BARD1 signaling events 10.0 585.0 57.0 -0.055 0.072 1000.0 -1000.0 -0.075 -1000.0 Cellular roles of Anthrax toxin 10.0 390.0 39.0 -0.087 0.012 1000.0 -1000.0 -0.03 -1000.0 Arf6 signaling events 10.0 621.0 62.0 -0.103 0.024 1000.0 -1000.0 -0.075 -1000.0 FAS signaling pathway (CD95) 10.0 487.0 47.0 -0.107 0.012 1000.0 -1000.0 -0.063 -1000.0 Canonical Wnt signaling pathway 10.0 558.0 51.0 -0.146 0.042 1000.0 -1000.0 -0.068 -1000.0 IL6-mediated signaling events 10.0 769.0 75.0 -0.139 0.04 1000.0 -1000.0 -0.1 -1000.0 Plasma membrane estrogen receptor signaling 10.0 872.0 86.0 -0.085 0.019 1000.0 -1000.0 -0.099 -1000.0 Regulation of Androgen receptor activity 10.0 726.0 70.0 -0.211 0.024 1000.0 -1000.0 -0.084 -1000.0 Lissencephaly gene (LIS1) in neuronal migration and development 9.0 500.0 54.0 -0.158 0.022 1000.0 -1000.0 -0.118 -1000.0 JNK signaling in the CD4+ TCR pathway 9.0 153.0 17.0 -0.049 0.011 1000.0 -1000.0 -0.066 -1000.0 Presenilin action in Notch and Wnt signaling 9.0 581.0 61.0 -0.135 0.03 1000.0 -1000.0 -0.084 -1000.0 Nectin adhesion pathway 9.0 579.0 63.0 -0.052 0.018 1000.0 -1000.0 -0.084 -1000.0 Integrins in angiogenesis 9.0 778.0 84.0 -0.106 0.019 1000.0 -1000.0 -0.104 -1000.0 EGFR-dependent Endothelin signaling events 9.0 192.0 21.0 -0.079 0.017 1000.0 -1000.0 -0.085 -1000.0 Angiopoietin receptor Tie2-mediated signaling 9.0 817.0 88.0 -0.092 0.036 1000.0 -1000.0 -0.131 -1000.0 Ras signaling in the CD4+ TCR pathway 9.0 164.0 17.0 -0.029 0.014 1000.0 -1000.0 -0.051 -1000.0 Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met) 8.0 741.0 85.0 -0.06 0.024 1000.0 -1000.0 -0.087 -1000.0 TRAIL signaling pathway 8.0 397.0 48.0 -0.038 0.022 1000.0 -1000.0 -0.077 -1000.0 S1P1 pathway 8.0 321.0 36.0 -0.086 0.011 1000.0 -1000.0 -0.071 -1000.0 IL2 signaling events mediated by STAT5 8.0 183.0 22.0 -0.06 0.012 1000.0 -1000.0 -0.081 -1000.0 FOXM1 transcription factor network 8.0 448.0 51.0 -0.157 0.107 1000.0 -1000.0 -0.207 -1000.0 Paxillin-independent events mediated by a4b1 and a4b7 7.0 269.0 37.0 -0.061 0.023 1000.0 -1000.0 -0.065 -1000.0 IL1-mediated signaling events 7.0 492.0 62.0 -0.068 0.055 1000.0 -1000.0 -0.105 -1000.0 S1P5 pathway 7.0 130.0 17.0 -0.085 0.041 1000.0 -1000.0 -0.039 -1000.0 IL2 signaling events mediated by PI3K 7.0 425.0 58.0 -0.069 0.027 1000.0 -1000.0 -0.099 -1000.0 HIV-1 Nef: Negative effector of Fas and TNF-alpha 7.0 324.0 45.0 -0.089 0.025 1000.0 -1000.0 -0.104 -1000.0 IGF1 pathway 7.0 449.0 57.0 -0.036 0.023 1000.0 -1000.0 -0.103 -1000.0 S1P4 pathway 7.0 179.0 25.0 -0.085 0.015 1000.0 -1000.0 -0.063 -1000.0 Sphingosine 1-phosphate (S1P) pathway 6.0 195.0 28.0 -0.085 0.017 1000.0 -1000.0 -0.044 -1000.0 Ceramide signaling pathway 6.0 490.0 76.0 -0.084 0.03 1000.0 -1000.0 -0.062 -1000.0 Regulation of p38-alpha and p38-beta 6.0 341.0 54.0 -0.116 0.029 1000.0 -1000.0 -0.078 -1000.0 Stabilization and expansion of the E-cadherin adherens junction 6.0 455.0 74.0 -0.082 0.059 1000.0 -1000.0 -0.097 -1000.0 Regulation of Telomerase 6.0 646.0 102.0 -0.155 0.031 1000.0 -1000.0 -0.109 -1000.0 S1P3 pathway 6.0 272.0 42.0 -0.085 0.019 1000.0 -1000.0 -0.055 -1000.0 a4b1 and a4b7 Integrin signaling 5.0 26.0 5.0 -0.008 0.009 1000.0 -1000.0 -0.03 -1000.0 Aurora A signaling 5.0 324.0 60.0 -0.088 0.028 1000.0 -1000.0 -0.066 -1000.0 EPO signaling pathway 5.0 323.0 55.0 -0.023 0.038 1000.0 -1000.0 -0.109 -1000.0 IFN-gamma pathway 5.0 396.0 68.0 -0.084 0.031 1000.0 -1000.0 -0.107 -1000.0 HIF-2-alpha transcription factor network 5.0 249.0 43.0 -0.047 0.048 1000.0 -1000.0 -0.106 -1000.0 TCGA08_rtk_signaling 5.0 148.0 26.0 -0.05 0.032 1000.0 -1000.0 -0.026 -1000.0 Class I PI3K signaling events 5.0 430.0 73.0 -0.098 0.028 1000.0 -1000.0 -0.074 -1000.0 Rapid glucocorticoid signaling 5.0 106.0 20.0 -0.044 0.013 1000.0 -1000.0 -0.023 -1000.0 Signaling events mediated by PRL 5.0 190.0 34.0 -0.091 0.018 1000.0 -1000.0 -0.055 -1000.0 PLK2 and PLK4 events 4.0 12.0 3.0 -0.002 0.011 1000.0 -1000.0 -0.019 -1000.0 Hedgehog signaling events mediated by Gli proteins 4.0 319.0 65.0 -0.252 0.039 1000.0 -1000.0 -0.081 -1000.0 ceramide signaling pathway 4.0 234.0 49.0 -0.084 0.02 1000.0 -1000.0 -0.066 -1000.0 Role of Calcineurin-dependent NFAT signaling in lymphocytes 4.0 347.0 83.0 -0.169 0.043 1000.0 -1000.0 -0.076 -1000.0 Signaling events mediated by HDAC Class I 4.0 449.0 104.0 -0.084 0.044 1000.0 -1000.0 -0.074 -1000.0 Signaling mediated by p38-alpha and p38-beta 4.0 218.0 44.0 -0.092 0.019 1000.0 -1000.0 -0.061 -1000.0 PDGFR-beta signaling pathway 4.0 481.0 97.0 -0.074 0.036 1000.0 -1000.0 -0.089 -1000.0 Aurora B signaling 4.0 270.0 67.0 -0.09 0.02 1000.0 -1000.0 -0.086 -1000.0 Canonical NF-kappaB pathway 3.0 126.0 39.0 -0.084 0.056 1000.0 -1000.0 -0.091 -1000.0 Signaling events mediated by HDAC Class II 3.0 272.0 75.0 -0.055 0.032 1000.0 -1000.0 -0.057 -1000.0 Aurora C signaling 3.0 25.0 7.0 -0.014 0.004 1000.0 -1000.0 -0.03 -1000.0 Signaling mediated by p38-gamma and p38-delta 3.0 49.0 15.0 -0.025 0.025 1000.0 -1000.0 -0.042 -1000.0 Paxillin-dependent events mediated by a4b1 3.0 129.0 36.0 -0.061 0.028 1000.0 -1000.0 -0.08 -1000.0 E-cadherin signaling in the nascent adherens junction 3.0 299.0 76.0 -0.047 0.036 1000.0 -1000.0 -0.095 -1000.0 Insulin Pathway 3.0 234.0 74.0 -0.078 0.03 1000.0 -1000.0 -0.094 -1000.0 E-cadherin signaling events 3.0 18.0 5.0 -0.004 0.013 1000.0 -1000.0 -0.029 -1000.0 Circadian rhythm pathway 2.0 59.0 22.0 -0.028 0.03 1000.0 -1000.0 -0.057 -1000.0 PDGFR-alpha signaling pathway 2.0 90.0 44.0 -0.067 0.028 1000.0 -1000.0 -0.072 -1000.0 FoxO family signaling 2.0 153.0 64.0 -0.117 0.088 1000.0 -1000.0 -0.091 -1000.0 Signaling events mediated by VEGFR1 and VEGFR2 2.0 286.0 125.0 -0.052 0.063 1000.0 -1000.0 -0.101 -1000.0 E-cadherin signaling in keratinocytes 2.0 115.0 43.0 -0.059 0.033 1000.0 -1000.0 -0.074 -1000.0 p38 MAPK signaling pathway 2.0 125.0 44.0 -0.084 0.025 1000.0 -1000.0 -0.086 -1000.0 Arf6 downstream pathway 1.0 78.0 43.0 -0.018 0.019 1000.0 -1000.0 -0.053 -1000.0 PLK1 signaling events 1.0 156.0 85.0 -0.012 0.026 1000.0 -1000.0 -0.062 -1000.0 Insulin-mediated glucose transport 1.0 61.0 32.0 -0.046 0.023 1000.0 -1000.0 -0.073 -1000.0 mTOR signaling pathway 1.0 89.0 53.0 -0.004 0.028 1000.0 -1000.0 -0.064 -1000.0 Class I PI3K signaling events mediated by Akt 1.0 84.0 68.0 -0.046 0.041 1000.0 -1000.0 -0.063 -1000.0 Atypical NF-kappaB pathway 1.0 33.0 31.0 -0.007 0.035 1000.0 -1000.0 -0.054 -1000.0 VEGFR1 specific signals 1.0 98.0 56.0 -0.02 0.049 1000.0 -1000.0 -0.081 -1000.0 Regulation of cytoplasmic and nuclear SMAD2/3 signaling 0.0 13.0 23.0 0.006 0.036 1000.0 -1000.0 -0.06 -1000.0 Sumoylation by RanBP2 regulates transcriptional repression 0.0 2.0 27.0 0.0 0.028 1000.0 -1000.0 -0.05 -1000.0 Arf6 trafficking events 0.0 66.0 71.0 -0.056 0.036 1000.0 -1000.0 -0.084 -1000.0 Arf1 pathway 0.0 29.0 54.0 -0.011 0.025 1000.0 -1000.0 -0.039 -1000.0 Alternative NF-kappaB pathway 0.0 7.0 13.0 -0.002 0.032 1000.0 -1000.0 -0.05 -1000.0 Total 1539 88830 7203 -15.9131124849 -995.013565725 131000 -131000 -10.2414660448 -131000